Health Care M&A Weekly Deals, The Week Ending June 1, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

 

Biotechnology
AcquirerTargetPrice
Denali Therapeutics Inc.F-star Gamma Ltd.$24 million
Zai Lab LimitedExclusive worldwide license to protein therapeuticsN/A
eHealth
AcquirerTargetPrice
ResMed Inc.HEALTHCAREfirstN/A
Aquiline Capital PartnersAspirion Health ResourcesN/A
Laboratories, MRI and Dialysis
AcquirerTargetPrice
Myriad Genetics, Inc.Counsyl, Inc.$375 million
Managed Care
AcquirerTargetPrice
WellCare Health Plans, Inc.

 

Meridian$2.5 billion
Pharmaceuticals
AcquirerTargetPrice
Newsoara Biopharma Co., Ltd.Exclusive rights to PDE4 inhibitor program in ChinaN/A
Acerus Pharmaceuticals CorporationExclusive rights to SHACTN/A
Link Health Group LTDExclusive license to Lidoderm in ChinaN/A
Physician Medical Groups
AcquirerTargetPrice
Revelstoke Capital PartnersCincinnati Eye InstituteN/A
Other
AcquirerTargetPrice
Linden Capital PartnersEvolution Research Group, LLCN/A
   

 

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *